Sumitomo Dainippon Pharma Co ( (JP:4506) ) has issued an announcement.
Sumitomo Pharma Co., Ltd. has announced an extension of reduced remuneration for its directors due to ongoing financial challenges and a lack of dividend distribution for the fiscal year ended March 31, 2025. This decision reflects the company’s efforts to navigate its current business difficulties and its commitment to financial recovery, impacting its executive compensation structure.
More about Sumitomo Dainippon Pharma Co
Sumitomo Pharma Co., Ltd. is a pharmaceutical company based in Osaka, Japan, focusing on the development and commercialization of pharmaceutical products. The company operates in the healthcare industry, providing a range of medications and therapies to address various medical needs.
YTD Price Performance: 29.19%
Average Trading Volume: 625
Technical Sentiment Signal: Sell
Current Market Cap: $1.66B
Learn more about 4506 stock on TipRanks’ Stock Analysis page.